Current liabilities decreased 38.9%
Current liabilities changed -38.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$222.6M→$135.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FFAI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital increased 42.6%
Working capital changed +42.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$146.0M→-$83.8M4 prior comparisons
Working capital / assets moved 658 bp higher
Working capital / assets changed +658 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-36.52%→-29.94%4 prior comparisons
Gross margin moved 4845689 bp higher
Gross margin changed +4845689 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-49737.04%→-1280.14%3 prior comparisons
Current assets decreased 31.9%
Current assets changed -31.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$76.6M→$52.1M4 prior comparisons
Operating income increased 27.6%
Operating income changed +27.6% from the comparable as-filed period.
-$48.1M→-$34.8M3 prior comparisons
Gross profit increased 60.2%
Gross profit changed +60.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$26.9M→-$10.7M3 prior comparisons
Operating margin moved 8492298 bp higher
Operating margin changed +8492298 basis points from the comparable as-filed period.
-89088.89%→-4165.91%3 prior comparisons
Net income increased 71.1%
Net income changed +71.1% from the comparable as-filed period.
-$124.7M→-$36.0M3 prior comparisons
Inventory decreased 86.2%
Inventory changed -86.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$23.1M→$3.2M4 prior comparisons
Stock-based compensation decreased 47.0%
Stock-based compensation changed -47.0% from the comparable as-filed period.
$893,000→$473,0003 prior comparisons
Trade receivables decreased 38.0%
Trade receivables changed -38.0% from the comparable as-filed period.
$645,000→$400,0003 prior comparisons
Total assets decreased 30.0%
Total assets changed -30.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$399.7M→$279.8M4 prior comparisons
Revenue changed across a low base
Revenue changed +1448.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 3 consecutive comparable moves in the opposite direction.
$54,000→$836,0003 prior comparisons
Capital expenditure decreased 58.0%
Capital expenditure changed -58.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$3.4M→$1.4M4 prior comparisons
Cash & equivalents decreased 15.4%
Cash & equivalents changed -15.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$13.2M→$11.2M3 prior comparisons
Capex / revenue moved 619555 bp lower
Capex / revenue changed -619555 basis points from the comparable as-filed period.
6368.52%→172.97%3 prior comparisons
Inventory / revenue moved 4240235 bp lower
Inventory / revenue changed -4240235 basis points from the comparable as-filed period.
42783.33%→380.98%3 prior comparisons
SBC / revenue moved 159712 bp lower
SBC / revenue changed -159712 basis points from the comparable as-filed period.
1653.70%→56.58%3 prior comparisons
Operating cash flow decreased 7.5%
Operating cash flow changed -7.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$23.3M→-$25.1M4 prior comparisons
Research & development decreased 17.2%
Research & development changed -17.2% from the comparable as-filed period.
$5.0M→$4.1M3 prior comparisons
Free-cash-flow proxy increased 0.9%
Free-cash-flow proxy changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-$26.8M→-$26.5M4 prior comparisons
R&D / revenue moved 877109 bp lower
R&D / revenue changed -877109 basis points from the comparable as-filed period.
9266.67%→495.57%3 prior comparisons
Free-cash-flow margin moved 4637076 bp higher
Free-cash-flow margin changed +4637076 basis points from the comparable as-filed period.
-49540.74%→-3169.98%3 prior comparisons
Operating cash-flow margin moved 4017521 bp higher
Operating cash-flow margin changed +4017521 basis points from the comparable as-filed period.
-43172.22%→-2997.01%3 prior comparisons
Receivables / revenue moved 114660 bp lower
Receivables / revenue changed -114660 basis points from the comparable as-filed period.
1194.44%→47.85%3 prior comparisons
Current ratio increased 11.5%
Current ratio changed +11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
0.34→0.384 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.